MedTrace Logo

Racial Differences: Nitric Oxide(NO) and Endothelin-1(ET-1) in Preeclampsia (PreE)

NCT00653809 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2012-04-06

No results posted yet for this study

Summary

The goal of this study is to examine the activation of markers of endothelial and cardiovascular dysfunctions, from women with high-risk pregnancies. Information from this study will hopefully provide enough information to determine a link between race, the advent of high risk pregnancies and cardiovascular markers. With this information it might be possible to intervene with approved pharmacological treatments.

Conditions

Sponsors & Collaborators

  • Office of Minority Health

    collaborator UNKNOWN

  • Mississippi Institute for Improvement of Geographic Minority Health

    collaborator UNKNOWN

  • University of Mississippi Medical Center

    lead OTHER

Principal Investigators

  • Kedra L Wallace, PhD · Obstetrics & Gynecology

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2008-12-31
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00653809 on ClinicalTrials.gov